Article
A Multidimensional Workflow Profiling of Allogeneic EBV-Specific T-cell Therapies Reveals Potency-Linked Signatures
2025-05-15
Abstract excerpt
<title>Abstract</title> <p>Allogeneic Epstein-Barr virus (EBV)-specific T cell therapies offer distinct advantages, including scalability, rapid deployment, and manufacturing consistency, and have demonstrated efficacy in multiple clinical trials. Here, we present a multidimensional analytical platform that integrates in vitro and in vivo anti-viral reactivity, T cell receptor (TCR) repertoire analysis, gene expr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 276020b7-ade4-52a2-b67a-beaa5f49f091
- DOI
- 10.21203/rs.3.rs-6544259/v1
